Victoria Alcazar

Leganes, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Physician and hospital determinants of levothyroxine treatment adequacy in low-risk papillary thyroid carcinoma.

Physician and hospital determinants of levothyroxine treatment adequacy in low-risk papillary thyroid carcinoma.

Journal: Frontiers in endocrinology

Published: March 01, 2026

Real-World outcomes and prognostic factors in anaplastic thyroid cancer: Evidence from the REGETNE-Thyroid cohort.

Real-World outcomes and prognostic factors in anaplastic thyroid cancer: Evidence from the REGETNE-Thyroid cohort.

Journal: The oncologist

Published: February 27, 2026

Real-world outcomes and prognostic factors in anaplastic thyroid cancer: evidence from the REGETNE-Thyroid cohort.

Real-world outcomes and prognostic factors in anaplastic thyroid cancer: evidence from the REGETNE-Thyroid cohort.

Journal: The oncologist

Published: February 27, 2026

Improved adequacy of levothyroxine treatment in low-risk differentiated thyroid cancer using the 2025 ATA criteria: a multicenter real-world analysis of 1,016 patients.

Improved adequacy of levothyroxine treatment in low-risk differentiated thyroid cancer using the 2025 ATA criteria: a multicenter real-world analysis of 1,016 patients.

Journal: European thyroid journal

Published: February 15, 2026

Predictive model for the diagnosis of ectopic Cushing syndrome.

Predictive model for the diagnosis of ectopic Cushing syndrome.

Journal: Endocrine-related cancer

Published: September 02, 2025

Recent Advances and Future Directions in Thermal, Electrical, and Mechanical Properties of Polymer Composites.

Recent Advances and Future Directions in Thermal, Electrical, and Mechanical Properties of Polymer Composites.

Journal: Polymers

Published: September 01, 2025

Assessment of levothyroxine therapy adequacy in low-risk differentiated thyroid carcinoma: a multicenter cohort study.

Assessment of levothyroxine therapy adequacy in low-risk differentiated thyroid carcinoma: a multicenter cohort study.

Journal: Frontiers in endocrinology

Published: June 24, 2025

Risk Factors for Pituitary Adenoma Development in Multiple Endocrine Neoplasia Type 1: A Nationwide Study of 240 Cases.

Risk Factors for Pituitary Adenoma Development in Multiple Endocrine Neoplasia Type 1: A Nationwide Study of 240 Cases.

Journal: The Journal of clinical endocrinology and metabolism

Published: February 19, 2025

Risk Factors Pituitary Adenomas Development in Multiple Endocrine Neoplasia Type 1: A Nationwide Study of 240 Cases.

Risk Factors Pituitary Adenomas Development in Multiple Endocrine Neoplasia Type 1: A Nationwide Study of 240 Cases.

Journal: The Journal of clinical endocrinology and metabolism

Published: February 19, 2025

Impaired renal function in patients with permanent hypoparathyroidism after thyroidectomy: analysis of a nationwide cohort in Spain.

Impaired renal function in patients with permanent hypoparathyroidism after thyroidectomy: analysis of a nationwide cohort in Spain.

Journal: Endocrine

Published: November 01, 2024

Prevalence of chronic postsurgical hypoparathyroidism not adequately controlled: an analysis of a nationwide cohort of 337 patients.

Prevalence of chronic postsurgical hypoparathyroidism not adequately controlled: an analysis of a nationwide cohort of 337 patients.

Journal: Frontiers in endocrinology

Published: July 14, 2024

Long term outcomes of pituitary adenomas in Multiple Endocrine Neoplasia type 1: a nationwide study.

Long term outcomes of pituitary adenomas in Multiple Endocrine Neoplasia type 1: a nationwide study.

Journal: Frontiers in endocrinology

Published: May 04, 2024

Showing 1-12 of 42

Last Updated: 09/26/2026